Focusing on specific immunosuppressive genes of tumor-associated macrophages (TAMs), Xu et al. indicated that, of the selective 10 tumor-promoting genes of TAMs, only MMP19 and SIRPα could predict ICI response in iCCA patients [51]. This evidence concerns the gene SIRPA and neoplasm.